Skip to main navigation Skip to search Skip to main content

A Basis for Fluoropyrimidine-Induced Antagonism to Methotrexate in Ehrlich Ascites Tumor Cells in Vitro

  • Donnell Bowen
  • , J. Courtl
  • , I. David Goldman

Research output: Contribution to journalArticlepeer-review

Abstract

The inhibitory effect of methotrexate on [3 H]deoxyuridine incorporation into DNA is reduced as the basal rate of this reaction is inhibited by pretreatment of Ehrlich ascites tumor cells with fluoropyrimidines. This observation is a basis for fluoropyrimidine-methotrexate antagonism in anticancer regimens and supports the concept that the sensitivity of thymidylate synthesis in tumor cells to methotrexate is related, in part, to the basal rate of thymidylate synthesis from deoxyuridylate.

Original languageEnglish (US)
Pages (from-to)219-222
Number of pages4
JournalCancer research
Volume38
Issue number1
StatePublished - Jan 1978
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'A Basis for Fluoropyrimidine-Induced Antagonism to Methotrexate in Ehrlich Ascites Tumor Cells in Vitro'. Together they form a unique fingerprint.

Cite this